APOA1 and breast cancer: To assess the anti-tumor effects of immune cells associated with oncolytic viruses, we established an orthotopic MDA-MB-231 nude mouse breast cancer model and treated it with intratumoral injections of PBS, ADV-Ctr, and ADV-ApoA1, respectively.